NASDAQ · Financial Statements
DNA X, Inc. (SONM) Financial Statements
$3.64
NASDAQ: SONM
Market Cap $5.42M
Overview Financials Dividend DNA X, Inc. most recently reported annual revenue of $0, net profit of $-21.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $55.0M $70.0M $94.0M $58.0M $0 Operating Profit $-38.0M $-14.0M $1.0M $-34.0M $-5.0M Net Profit $-39.0M $-14.0M $0 $-34.0M $-21.0M EPS $-734.62 $-87.77 $-0.39 $-128.37 $-28.58 Op Margin -69.6% -20.5% 0.6% -57.7% —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $41.0M $54.0M $56.0M $40.0M $44.0M Total Liabilities $22.0M $34.0M $34.0M $45.0M $51.0M Cash $11.0M $13.0M $9.0M $5.0M $1.0M Borrowings $0 $0 $0 $0 $5.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-38.0M $-12.0M $-4.0M $-8.0M $-24.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $0 $0 $0 Net Cash Flow $-11.0M $2.0M $-4.0M $-4.0M $-4.0M Free Cash Flow $-39.0M $-12.0M $-4.0M $-9.0M $-24.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.01 EV / EBITDA -2.89 FCF Yield -253.47% Quick Ratio 0.57 Interest Coverage -3.30 Return 1Y -70.33% Return 3Y -98.18% Return 5Y -99.49%
Screens featuring this stock